Satoshi Nagano

3.2k citations
120 papers · 2.5k indexed · h-index 28
Topics
Sarcoma Diagnosis and Treatment (20 papers)Bone Tumor Diagnosis and Treatments (10 papers)Virus-based gene therapy research (9 papers)

In The Last Decade

Satoshi Nagano

113 papers receiving 2.4k citations

Peers

Satoshi Nagano
Comparison fields: 5 of 156
  • Molecular Biology 874
  • Surgery 535
  • Oncology 382
  • Pulmonary and Respiratory Medicine 330
  • Genetics 262
Replace Jeong‐Wook Seo with:
Jeong‐Wook Seo South Korea
Iwona Cicha Germany
Jason A. Spector United States
Lewis L. Shi United States
Nicholas P. Ziats United States
Peng Xu China
Yahye Merhi Canada
Xisheng Weng China
Bin Feng China
Huiqi Xie China
Satoshi Nagano relative to Jeong‐Wook Seo South Korea Jeong‐Wook Seo's profile →
Citations per field
00.5×2.5×
Jeong‐Wook Seo · 1×
Citations per year

Countries citing papers authored by Satoshi Nagano

Since Specialization
Citations

This map shows the geographic impact of Satoshi Nagano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoshi Nagano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoshi Nagano more than expected).

Fields of papers citing papers by Satoshi Nagano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoshi Nagano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoshi Nagano. The network helps show where Satoshi Nagano may publish in the future.

Co-authorship network of co-authors of Satoshi Nagano

This figure shows the co-authorship network connecting the top 25 collaborators of Satoshi Nagano. A scholar is included among the top collaborators of Satoshi Nagano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoshi Nagano. Satoshi Nagano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 17
3 18
4 4
5 5
6 7
7 17
8 25
9 1
10 52
11 0
12 62
13 91
14 3
15 10
16 0
17 86
18 33
19 18
20
Meo for Telemedicine
1

About Satoshi Nagano

Satoshi Nagano is a scholar working on Rheumatology, Oral Surgery and Oncology, having authored 120 papers that have together received 2.5k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (20 papers), Bone Tumor Diagnosis and Treatments (10 papers) and Virus-based gene therapy research (9 papers). The work is most often cited by research in Rheumatology (245 citations), Oncology (382 citations) and Internal Medicine (51 citations). Satoshi Nagano has collaborated with scholars based in Japan, United States and Tanzania. Frequent co-authors include Setsuro Komiya, Takao Setoguchi, Yasuhiro Ishidou, Hisayoshi Fujiwara, Ken-ichiro Kosai, Masahiro Yokouchi, Kohei Sanui, Tomoyuki Takahashi, Takuya Yamamoto and Masayoshi Watanabe. Their work appears in journals such as Journal of Biological Chemistry, Circulation and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026